FR3083234B1 - Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation - Google Patents

Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation Download PDF

Info

Publication number
FR3083234B1
FR3083234B1 FR1855952A FR1855952A FR3083234B1 FR 3083234 B1 FR3083234 B1 FR 3083234B1 FR 1855952 A FR1855952 A FR 1855952A FR 1855952 A FR1855952 A FR 1855952A FR 3083234 B1 FR3083234 B1 FR 3083234B1
Authority
FR
France
Prior art keywords
cyclodextrins
beta
preparation methods
hpβcd
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1855952A
Other languages
English (en)
Other versions
FR3083234A1 (fr
Inventor
Clothilde Buffe
Joel Delattre
Vincent Wiatz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roquette Freres SA
Original Assignee
Roquette Freres SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1855952A priority Critical patent/FR3083234B1/fr
Application filed by Roquette Freres SA filed Critical Roquette Freres SA
Priority to CA3104568A priority patent/CA3104568A1/fr
Priority to KR1020207037131A priority patent/KR20210027279A/ko
Priority to PCT/FR2019/051602 priority patent/WO2020002851A1/fr
Priority to US17/255,153 priority patent/US20210253746A1/en
Priority to EP19752213.9A priority patent/EP3814386A1/fr
Priority to SG11202013126QA priority patent/SG11202013126QA/en
Priority to MX2020013689A priority patent/MX2020013689A/es
Priority to JP2020573107A priority patent/JP2021529243A/ja
Priority to CN201980044053.4A priority patent/CN112334494A/zh
Publication of FR3083234A1 publication Critical patent/FR3083234A1/fr
Application granted granted Critical
Publication of FR3083234B1 publication Critical patent/FR3083234B1/fr
Priority to IL279845A priority patent/IL279845A/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention se rapporte à une nouvelle hydroxypropyl-β-cyclodextrine (HPβCD) ainsi qu'à un nouveau procédé utile à sa préparation. L'invention se rapporte également à l'utilisation de cette HPβCD comme excipient. L'invention concerne également une HPβCD pour son utilisation comme médicament, et plus particulièrement pour le traitement ou la prévention de maladies ou conditions liées à une surcharge, et/ou à un stockage, et/ou à l'accumulation de cholestérol dans les tissus, ainsi que leurs conséquences, telles que certaines affections du système nerveux central ou du système cardio-vasculaire.
FR1855952A 2018-06-29 2018-06-29 Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation Active FR3083234B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR1855952A FR3083234B1 (fr) 2018-06-29 2018-06-29 Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation
JP2020573107A JP2021529243A (ja) 2018-06-29 2019-06-28 新規なヒドロキシプロピル−β−シクロデキストリン及びそれを生成するための方法
PCT/FR2019/051602 WO2020002851A1 (fr) 2018-06-29 2019-06-28 NOUVELLE HYDROXYPROPYL-β-CYCLODEXTRINE ET SON PROCÉDÉ DE PRÉPARATION
US17/255,153 US20210253746A1 (en) 2018-06-29 2019-06-28 Novel hydroxypropyl-beta-cyclodextrin and process for the production thereof
EP19752213.9A EP3814386A1 (fr) 2018-06-29 2019-06-28 NOUVELLE HYDROXYPROPYL-ß-CYCLODEXTRINE ET SON PROCÉDÉ DE PRÉPARATION
SG11202013126QA SG11202013126QA (en) 2018-06-29 2019-06-28 NOVEL HYDROXYPROPYL-ß-CYCLODEXTRIN AND PROCESS FOR THE PRODUCTION THEREOF
CA3104568A CA3104568A1 (fr) 2018-06-29 2019-06-28 Melange de molecules d'hydroxypropyl-.beta.-cyclodextrine et son procede de preparation
KR1020207037131A KR20210027279A (ko) 2018-06-29 2019-06-28 신규 히드록시프로필-β-사이클로덱스트린 및 이의 제조 방법
CN201980044053.4A CN112334494A (zh) 2018-06-29 2019-06-28 新颖的羟丙基-β-环糊精及其生产方法
MX2020013689A MX2020013689A (es) 2018-06-29 2019-06-28 Hidroxipropil-?-ciclodextrina novedosa y proceso para la producción de esta.
IL279845A IL279845A (en) 2018-06-29 2020-12-29 Hydroxypropyl beta-cyclodextrin and a process for its preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1855952 2018-06-29
FR1855952A FR3083234B1 (fr) 2018-06-29 2018-06-29 Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation

Publications (2)

Publication Number Publication Date
FR3083234A1 FR3083234A1 (fr) 2020-01-03
FR3083234B1 true FR3083234B1 (fr) 2020-11-27

Family

ID=65031319

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1855952A Active FR3083234B1 (fr) 2018-06-29 2018-06-29 Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation

Country Status (1)

Country Link
FR (1) FR3083234B1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
FR2735136B1 (fr) * 1995-06-08 1997-08-14 Roquette Freres Composition pulverulente d'hydroxypropyl-betacyclodextrine et son procede de preparation.
FR2738149B1 (fr) * 1995-09-06 1997-11-14 Chauvin Lab Sa Collyre a base d'indometacine pret a l'emploi
EP1655034A1 (fr) * 2004-10-10 2006-05-10 Université de Liège Utilisation d'un composé de cyclodextrine pour le traitement et la prévention des maladies inflammatoires bronchiques.
WO2013004462A1 (fr) * 2011-07-01 2013-01-10 Fondazione Istituto Insubrico Di Ricerca Per La Vita Complexe de tomoxiprole amorphe et de cyclodextrine présentant une vitesse de dissolution élevée et son procédé de préparation
FR3014694B1 (fr) * 2013-12-13 2016-11-11 Roquette Freres Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl
KR20180035787A (ko) 2015-06-10 2018-04-06 브이테스, 인코포레이티드 히드록시프로필 베타-시클로덱스트린 조성물 및 방법

Also Published As

Publication number Publication date
FR3083234A1 (fr) 2020-01-03

Similar Documents

Publication Publication Date Title
MA44795A (fr) Compositions de pyrrolopyrrole en tant qu'activateurs de la pyruvate kinase (pkr)
MA39225A1 (fr) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tétrahydropyridines utilisées en tant qu'inhibiteurs de bace1 dans le traitement de la maladie d'alzheimer
MA30333B1 (fr) Aminotetrahydropyranes utiles en tant qu'inhibiteurs de la dipeptidyle peptidase-iv pour le traitement ou la prevention du diabete.
MA47399B1 (fr) Dérivés de 7-phényléthylamino-4h-pyrimido[4,5-d][1,3]oxazin-2-one en tant qu'inhibiteurs de la forme mutée des protéines idh1 et idh2
MA30782B1 (fr) Amides substitues, procede de production et d'utilisation desdits amides
MA35246B1 (fr) 1,3-oxazines en tant qu'inhibiteurs de bace1 et/ou de bace2
ATE360441T1 (de) Komplement-inhibitoren die an c5 und c5a binden ohne die bildung von c5b zu hemmen
MA29652B1 (fr) 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
MA30018B1 (fr) Derives de 1-orthofluorophenyl substitues 1, 2, 5-thiazolidinedione utilises comme inhibiteurs de la ptp-ase
MA33000B1 (fr) Dicyanopyridine a substitution alkylamino et ses promedicaments d'ester d'acide amine
MA35874B1 (fr) Dérivés d'amide cycliques à utiliser en tant qu'inhibiteurs de 11-bêta-hydroxystéroïde déshydrogénase et utilisations de ceux-ci
MA41238A (fr) Dérivés 5-[(pipérazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione en tant qu'inhibiteurs d'adamts pour le traitement de l'ostéoarthrit
MA34019B1 (fr) Aryltriazolone liée à un bis-aryle et son utilisation
MA29411B1 (fr) 1h-quinazoline -2,4-diones et leur utilisation en tant que ligands du recepteur ampa
TNSN01009A1 (fr) (+) - 6 - [amino - (6 - chloro - pyridine - 3 - yl) - (3 - methyl - 3h - imidazole - 4 - yl) - methyl ] - 4 - ( 3 - chloro-phenyl) -1- cyclopropylmethyl - 1h - quinoleine - 2 - one, procede pour sa preparation et composition la contenant
MA28077A1 (fr) Derives d'isoquinilone 1,4-disubstitues en tant qu'inhibiteurs de raf-kinase utiles pour le traitement de maladies proliferantes
MA38099A1 (fr) Des nouveaux composes triazolopyrazines substitues inhibiteurs des brd4
MA29620B1 (fr) Nouveau derive de 1,4-benzothiazepine-1,1-dioxyde presentant des proprietes ameliorees, procede pour sa preparation, medicaments contenant ce compose, et son utilisation
MA34175B1 (fr) Anticorps anti-cxcr4 humanisés pour le traitement de cancer
MA38391A1 (fr) Dérivés de pyridinyl et triazolone pyridinyl de fusion
EA200971050A1 (ru) Способы лечения и предупреждения нейродегенеративных заболеваний и нарушений
MA35875B1 (fr) Dérivés d'aza-adamantane et leurs utilisations
MA37763A1 (fr) Difluoro-hexahydro-cyclopentaoxazinyles et difluoro-hexahydro-benzooxazinyles en tant qu'inhibiteurs de bace1
TN2014000542A1 (fr) Pansement a liberation prolongee d'actifs
FR3086943B1 (fr) Copolymere d'ethylene et de beta-farnesene

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200103

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7